Market revenue in 2023 | USD 2.6 million |
Market revenue in 2030 | USD 3.5 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Research & manufacturing |
Fastest growing segment | OUTPATIENT FACILITIES |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OUTPATIENT FACILITIES, RESEARCH & MANUFACTURING, HOSPITALS |
Key market players worldwide | Jeol Ltd, Thermo Fisher Scientific Inc, Bruker Corp, Oxford Instruments PLC, Nanalysis Scientific Corp Ordinary Shares, Absci Corp, QuinStreet Inc, Magritek Ltd, Magnetic Resonance Innovations |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear magnetic resonance spectroscopy market will help companies and investors design strategic landscapes.
Research & manufacturing was the largest segment with a revenue share of 46.15% in 2023. Horizon Databook has segmented the Saudi Arabia nuclear magnetic resonance spectroscopy market based on outpatient facilities, research & manufacturing, hospitals covering the revenue growth of each sub-segment from 2018 to 2030.
The growth in Saudi Arabia NMR spectroscopy market can be attributed to various initiatives being undertaken by the government to expand the biotechnology sector in the country. Organizations such as the King Abdullah University of Science and Technology (KAUST) facilitate biotechnology R&D activities in Saudi Arabia.
Furthermore, increasing private & public partnerships for expanding biopharmaceutical industry are anticipated to boost the demand for NMR spectroscopy products. For instance, in October 2019, Saudi Arabian Investment Authority (SAGIA) signed a Memorandum of understanding (MOU) with Korea’s GL Rapha Co. to manufacture biological drugs worth USD 320 million in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia nuclear magnetic resonance spectroscopy market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia nuclear magnetic resonance spectroscopy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account